Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Person

Lynn Kirkpatrick

Tracked across 4 events · 24 articles · First seen Jun 26, 2026 · Last active Sep 02, 2026

Sentiment
20
Attention
4
Events
4
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 60
Tech
Impact: Lynn Kirkpatrick, as CEO of Altor BioScience, provided key statements regarding the significance of the PF614-MPAR technology in addressing the opioid crisis and establishing a new standard for opioid safety.
Jun 26, 2026 · 6 articles
1 10
Tech
Impact: As CEO, Lynn Kirkpatrick is a featured speaker and spokesperson, representing the company's leadership in the symposium.
Aug 20, 2026 · 6 articles
2 10
Business
Impact: As CEO, Lynn Kirkpatrick is the public face of the announcement and her leadership is central to the company's progress. The event reflects positively on her management.
Aug 31, 2026 · 6 articles
0 0
Business
Impact: Lynn Kirkpatrick is the CEO of Ensysce and is listed as a company contact; her role is unchanged.
Sep 02, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Lynn Kirkpatrick live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.